IMRX · Immuneering Corp
Market Cap
$337.07M
Shares
64.70M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-05 | — | |
| 10-Q | 2026-08-05 | 2026-06-30 | |
| 8-K | 2026-06-15 | 2026-06-11 | |
| 8-K | 2026-06-11 | — | |
| 8-K | 2026-06-01 | — | |
| 8-K | 2026-05-15 | — | |
| 10-Q | 2026-05-15 | 2026-03-31 | |
| DEF 14A | 2026-04-20 | — | |
| 8-K | 2026-03-06 | — | |
| 10-K | 2026-03-06 | 2025-12-31 | |
| 8-K | 2026-01-07 | — | |
| 8-K | 2025-11-12 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-09-25 | 2025-09-24 | |
| 8-K | 2025-09-24 | — | |
| 8-K | 2025-08-25 | 2025-08-21 | |
| 10-Q | 2025-08-13 | 2025-06-30 | |
| 8-K | 2025-08-13 | — | |
| 8-K | 2025-06-17 | — | |
| 8-K | 2025-06-16 | 2025-06-13 | |
| 8-K | 2025-05-05 | — | |
| 10-Q | 2025-05-05 | 2025-03-31 | |
| DEF 14A | 2025-04-21 | — | |
| 10-K | 2025-03-20 | 2024-12-31 | |
| 8-K | 2025-03-20 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2025-01-07 | — | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-11-13 | — | |
| 8-K/A | 2024-10-02 | 2024-03-11 | |
| 8-K | 2024-09-12 | — | |
| 8-K | 2024-08-06 | — | |
| 10-Q | 2024-08-06 | 2024-06-30 | |
| 8-K | 2024-06-13 | 2024-06-12 | |
| 8-K | 2024-05-23 | 2024-05-21 | |
| 8-K | 2024-05-07 | — | |
| 10-Q | 2024-05-07 | 2024-03-31 | |
| DEF 14A | 2024-04-23 | — | |
| 8-K | 2024-03-14 | 2024-03-11 | |
| 8-K | 2024-03-01 | — | |
| 10-K | 2024-03-01 | 2023-12-31 | |
| 8-K | 2024-02-02 | 2024-02-01 | |
| 8-K | 2023-11-09 | — | |
| 10-Q | 2023-11-09 | 2023-09-30 | |
| 10-Q | 2023-08-03 | 2023-06-30 | |
| 8-K | 2023-08-03 | — | |
| 8-K | 2023-06-15 | 2023-06-14 | |
| 8-K | 2023-06-14 | 2023-06-13 | |
| 8-K | 2023-05-04 | — | |
| 10-Q | 2023-05-04 | 2023-03-31 |
Showing 1–50 of 73 filings
Key facts
CIK
1790340
CUSIP
45254E107
13F (30d)
96 filings
96 filers
Visit website
Investor relations